Role of tumor-associated gangliosides in cancer progression.
暂无分享,去创建一个
[1] S. Ladisch,et al. Shedding of gangliosides by human medulloblastoma cells. , 1997, Experimental cell research.
[2] M. Melamed,et al. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Dumontet,et al. Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides , 1994, Cancer Immunology, Immunotherapy.
[4] Gary R. Grotendorst,et al. Glycolipids: Receptors for fibronectin? , 1981, Journal of cellular physiology.
[5] S. Ladisch,et al. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides. , 1996, Cancer research.
[6] R. Yu,et al. Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Yu,et al. Down‐Regulation of GD3 Ganglioside and Its O‐Acetylated Derivative by Stable Transfection with Antisense V , 2000, Journal of neurochemistry.
[8] Ruixiang Li,et al. Tumor gangliosides inhibit the tumor-specific immune response. , 1999, Journal of immunology.
[9] K. Handa,et al. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. , 2001, International journal of oncology.
[10] H. Kleinman,et al. Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Yoshino,et al. Glycosphingolipid composition of murine neuroblastoma cells: O-acetylesterase gene downregulates the expression of O-acetylated GD3. , 1995, Biochemistry.
[12] L. D. Bergel'son,et al. [Glycosphingolipids and antitumor immunity]. , 1987, Eksperimental'naia onkologiia.
[13] L. Ulsh,et al. Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. , 1984, The Journal of clinical investigation.
[14] H. Offner,et al. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. , 1987, Journal of immunology.
[15] A. Paller,et al. Ganglioside GT1b inhibits keratinocyte adhesion and migration on a fibronectin matrix. , 1995, The Journal of investigative dermatology.
[16] K. Furukawa,et al. Gangliosides in Melanoma , 1990 .
[17] D. Sgroi,et al. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. , 1993, The Journal of biological chemistry.
[18] N. Kanda. Gangliosides GD1a and GM3 induce interleukin-10 production by human T cells. , 1999, Biochemical and biophysical research communications.
[19] T. Tencomnao,et al. Effect of N‐Glycosylation on Turnover and Subcellular Distribution of N‐Acetylgalactosaminyltransferase I and Sialyltransferase II in Neuroblastoma Cells , 2000, Journal of neurochemistry.
[20] Y. Hannun. Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.
[21] R. Yu,et al. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. , 1999, Biochemistry.
[22] S. Hakomori,et al. Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. , 1991, The Journal of biological chemistry.
[23] D. Bigner,et al. Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. , 1991, Cancer research.
[24] G. Pilkington,et al. Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro , 1994, Neuroscience Letters.
[25] Ruixiang Li,et al. Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation. , 2002, Glycobiology.
[26] S. Spiegel,et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.
[27] E. Ruoslahti,et al. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2 , 1987, The Journal of cell biology.
[28] L. Ulsh,et al. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. , 1992, Biochimica et biophysica acta.
[29] J. Miyazaki,et al. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA , 1997, International journal of cancer.
[30] N. Radin,et al. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. , 1990, Cancer research.
[31] P. Black. Shedding from normal and cancer-cell surfaces. , 1980, The New England journal of medicine.
[32] K. Takamiya,et al. Attenuation of Interleukin 2 Signal in the Spleen Cells of Complex Ganglioside-lacking Mice* , 1999, The Journal of Biological Chemistry.
[33] B. Sordat,et al. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.
[34] K. Furukawa,et al. Biosynthesis and functions of gangliosides: recent advances , 1998, Glycoconjugate Journal.
[35] Y. Watanabe,et al. Cloning and expression of cDNA for O-acetylation of GD3 ganglioside. , 1996, Biochemical and biophysical research communications.
[36] P. Gullino,et al. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[37] S. Ladisch,et al. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. , 1992, Cellular immunology.
[38] D. Irani. Brain-derived gangliosides induce cell cycle arrest in a murine T cell line , 1998, Journal of Neuroimmunology.
[39] A. Pavan,et al. A Novel Mechanism of CD4 Down-modulation Induced by Monosialoganglioside GM3 , 1998, The Journal of Biological Chemistry.
[40] Ruixiang Li,et al. Shedding of human neuroblastoma gangliosides. , 1991, Biochimica et biophysica acta.
[41] S. Hakomori. Inaugural Article : The glycosynapse , 2002 .
[42] M. Higashiyama,et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. , 1996, Cancer research.
[43] J. Haas,et al. Gangliosides suppress tumor necrosis factor production in human monocytes. , 1992, Journal of immunology.
[44] A. Paller,et al. Carbohydrate-Carbohydrate Binding of Ganglioside to Integrin α5 Modulates α5β1Function* , 2001, The Journal of Biological Chemistry.
[45] K. Handa,et al. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression , 2001, FEBS letters.
[46] Ruixiang Li,et al. Natural forms of shed tumor gangliosides. , 1998, Biochimica et biophysica acta.
[47] K. Sandhoff,et al. Ganglioside metabolism. Enzymology, Topology, and regulation. , 1993, The Journal of biological chemistry.
[48] P. Brodt,et al. Liver in Response to Metastatic Tumor Cells Rapid Induction of Cytokine and E-Selectin Expression in the Updated Version , 1999 .
[49] D. Sgroi,et al. Siglecs: a family of sialic-acid binding lectins. , 1998, Glycobiology.
[50] Ruixiang Li,et al. Enrichment and localization of ganglioside G(D3) and caveolin-1 in shed tumor cell membrane vesicles. , 2000, Biochimica et biophysica acta.
[51] J. Kirkwood,et al. Gangliosides of normal and neoplastic human melanocytes. , 1984, Biochemical and biophysical research communications.
[52] S. Hakomori. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.
[53] G. Pilkington,et al. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. , 1996, Cancer letters.
[54] A. Abe,et al. Improved Inhibitors of Glucosylceramide Synthase* , 1999, The Journal of Biological Chemistry.
[55] K. Handa,et al. Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. , 1992, The Journal of biological chemistry.
[56] W. Dippold,et al. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. , 1984, Cancer research.
[57] K. Handa,et al. A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. , 1997, Biochemical and biophysical research communications.
[58] L. Ulsh,et al. Immunosuppressive activity of human neuroblastoma tumor gangliosides , 1989, International journal of cancer.
[59] F. Sharom,et al. Interleukin-2 binds to gangliosides in micelles and lipid bilayers. , 1990, Biochimica et biophysica acta.
[60] R. Yu,et al. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. , 2000, Cancer research.
[61] S. Ladisch,et al. Influence of cellular ganglioside depletion on tumor formation. , 2000, Journal of the National Cancer Institute.
[62] L. Valentino,et al. Localization of shed human tumor gangliosides: association with serum lipoproteins. , 1992, Cancer research.
[63] A. Slominski,et al. Down‐Regulation of the Expression of O‐Acetyl‐GD3 by the O‐Acetylesterase cDNA in Hamster Melanoma Cells , 1999, Journal of neurochemistry.
[64] D. Morton,et al. Ganglioside GM3:GD3 ratio as an index for the management of melanoma , 1991, Cancer.
[65] M. Mareel,et al. Monosialyl‐Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF‐7 cells defines their invasive properties , 2002, FEBS letters.
[66] Ruixiang Li,et al. Ceramide structure predicts tumor ganglioside immunosuppressive activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[67] F. Sharom,et al. Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment. , 1995, Immunology.
[68] Y. Hirabayashi,et al. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O-acetylated ganglioside: a putative acetyl-CoA transporter. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Yu,et al. Reduced cell migration, tumor growth and experimental metastasis of rat F‐11 cells whose expression of GD3‐synthase is suppressed , 2000, International journal of cancer.
[70] R. Yu,et al. Structures of some new complex gangliosides of fish brain. , 1980, Advances in experimental medicine and biology.
[71] P. Gullino,et al. Gangliosides promote the angiogenic response. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[72] F. Sharom,et al. Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation. , 1995, Immunology.
[73] Kazuro Furukawa,et al. Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. , 2001, Cancer research.
[74] T. Tencomnao,et al. Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferases. , 2002, Biochemistry.
[75] K. Handa,et al. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. , 2001, Biochemistry.
[76] L. Old,et al. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody , 1982, The Journal of experimental medicine.
[77] P. Massa,et al. Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides , 1993, The Journal of experimental medicine.
[78] F. Sharom,et al. Gangliosides and glycophorin inhibit T-lymphocyte activation. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[79] M. Ziche,et al. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. , 1999, Molecular biology of the cell.
[80] L. Frati,et al. Monosialoganglioside GM3 Induces CD4 Internalization in Human Peripheral Blood T Lymphocytes , 1995, Scandinavian journal of immunology.
[81] A. Varki,et al. Induction of sialic acid 9-O-acetylation by diverse gene products: implications for the expression cloning of sialic acid O-acetyltransferases. , 1998, Glycobiology.
[82] K. Claffey,et al. Gangliosides influence angiogenesis in an experimental mouse brain tumor. , 1999, Cancer research.
[83] M. Lotze,et al. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. , 2001, Cancer research.
[84] K. Handa,et al. Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility* , 2002, The Journal of Biological Chemistry.
[85] K. Mujoo,et al. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins , 1986, The Journal of cell biology.
[86] K. Yamaguchi,et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[87] C. Deng,et al. [A vital role for glycosphingolipid synthesis during development and differentiation]. , 1999, Seikagaku. The Journal of Japanese Biochemical Society.
[88] R. Proia,et al. Combinatorial Ganglioside Biosynthesis* , 2002, The Journal of Biological Chemistry.
[89] S. Kellie,et al. Gangliosides as receptors for fibronectin? Comparison of cell spreading on a ganglioside-specific ligand with that on fibronectin. , 1982, Experimental cell research.